bpc 157 human clinical trials systematic review BPC-157 as an Investigational Peptide Therapeutic: Biopharmaceutical Challenges, Formulation Strategies, and Translational Development Barriers BPC 157 for Bodybuilding: Muscle
Description
PMC Early clinical safety work: Phase 1/2 investigations with T4 examined IV/topical use and general tolerability, but did not establish approved indications
5 Journal of Investigative Dermatology (PubMed)Malinda KM, et al
Protective Effects of Moderate Hypothermia After Neonatal Hypoxia-Ischemia: Short- and Long-Term Outcome
,
